Actinium Pharmaceuticals, Inc. ATNM
1.44 USD +0.01 +0.70%
As of Nov 3, 11:32 AM ET
- Open
- 1.40
- Prev close
- 1.43
- Mkt cap
- 45.28M
- Vol
- 22.36K
- Avg vol
- 187.48K
- EPS
- 0.36
- P/E
- 4.00
- Div yield
- 0.00%
More statistics
- Low
- 1.42
- High
- 1.45
- Forward P/E
- -1.77
- Beta
- 0.15
- Short ratio
- 5.72
- Inst. own
- 30.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.55
- 200-d avg
- 4.86
- 1y target
- 5.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ATNM has not been loaded yet. Try again in a moment.
Altman Z-Score
-8.11 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
S-5 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 4
- P/B 4
P/E -1.2×
P/S 471×
P/B 5.4×
P/FCF -1.7×
EV/EBITDA 0.1×
EV/Sales -43.1×
FCF Yield -58.2%
Gross Margin 100.0%
Operating Margin -40274.4%
Net Margin -37652.2%
ROE -432.6%
ROIC -81.4%
ROA -65.5%
Revenue 0.0%
Operating Income 13.9%
EPS (diluted) 14.2%
Free Cash Flow 25.4%
Current Ratio 6.2×
Quick Ratio 6.2×
Debt / Equity 0.2×
Net Debt / EBITDA 1.4×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31